Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00747162

Muscle Oxygenation and Skin Pigmentation

Correlation Between Muscle Oxygenation and Skin Pigmentation

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The investigators plan to enroll 500 consecutive Subjects at a major trauma center for this study. For each patient, the body mass index (BMI), age, sex, diastolic pressure and mean arterial pressure (MAP) at time of measurements. Additional information including diseases such as diabetes and vascular disorders will be recorded. Social demographics including alcohol and tobacco use will be recorded. This is important as alcohol and tobacco use could also contribute to cardiovascular diseases. The skin pigmentation of each subject will be recorded. Two different methods will be used for this measurement. Each patient will be graded on a six point scale as described by Young (Young, 1997). Additionally, each subject will have their skin measured using a reflectance colorimeter. The colorimeter, DermaSpectrometer II (cyberDerm, Broomall, PA) uses visible light to measure the amount of light reflected off the skin. By measuring the light reflectance, the skin pigmentation can be measure (Clarys, 2000). Muscle oxygenation will be measured using a continuous dual wavelength near infrared spectrometer. Using the different absorption characteristics of deoxyhemoglobin and oxyhemoglobin, the concentration of oxyhemoglobin in the muscle at an approximate depth of 2.5 cm is determined. The INVOS cerebral oximeter (Somanetics, Troy, MI) will be used for all measurements.

Conditions

Interventions

TypeNameDescription
DEVICEMeasure of muscle oxygenationThe investigators will use an INVOS oxymeter for muscle oxygenation measure.
DEVICESkin pigmentation determinationThe investigators will use a DermaSpectrometer to get a reading from subjects' skin color

Timeline

Start date
2008-08-01
Primary completion
2009-01-01
Completion
2009-02-01
First posted
2008-09-04
Last updated
2013-11-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00747162. Inclusion in this directory is not an endorsement.